{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:50:43Z","timestamp":1791111043662,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jsbmb.2013.05.008","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T02:19:02Z","timestamp":1370571542000},"page":"150-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Effects of menopausal hormonal therapy on occult breast tumors"],"prefix":"10.1016","volume":"137","author":[{"given":"Richard J.","family":"Santen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Heitjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jsbmb.2013.05.008_bib0005","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.7326\/0003-4819-127-11-199712010-00014","article-title":"Using autopsy series to estimate the disease \u201creservoir\u201d for ductal carcinoma in situ of the breast: how much more breast cancer can we find?","volume":"127","author":"Welch","year":"1997","journal-title":"Annals of Internal Medicine"},{"issue":"7:Suppl. 1","key":"10.1016\/j.jsbmb.2013.05.008_bib0010","article-title":"Postmenopausal hormone therapy: an Endocrine Society scientific statement [Review] [511 refs]","volume":"95","author":"Santen","year":"2010","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"11","key":"10.1016\/j.jsbmb.2013.05.008_bib0015","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1097-0142(19871201)60:11<2751::AID-CNCR2820601127>3.0.CO;2-M","article-title":"Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study","volume":"60","author":"Bartow","year":"1987","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jsbmb.2013.05.008_bib0020","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/bjc.1987.296","article-title":"Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies","volume":"56","author":"Nielsen","year":"1987","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.05.008_bib0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/bjc.1985.39","article-title":"Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women","volume":"51","author":"Bhathal","year":"1985","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.05.008_bib0030","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5858\/2000-124-0378-PMPFIH","article-title":"Prophylactic mastectomy: pathologic findings in high-risk patients","volume":"124","author":"Khurana","year":"2000","journal-title":"Archives of Pathology & Laboratory Medicine"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.05.008_bib0035","first-page":"231","article-title":"An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions","volume":"55","author":"Wellings","year":"1975","journal-title":"Journal of the National Cancer Institute"},{"issue":"8","key":"10.1016\/j.jsbmb.2013.05.008_bib0040","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0046-8177(85)80251-3","article-title":"The prevalence of carcinoma in situ in normal and cancer-associated breasts","volume":"16","author":"Alpers","year":"1985","journal-title":"Human Pathology"},{"issue":"22","key":"10.1016\/j.jsbmb.2013.05.008_bib0045","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"issue":"18","key":"10.1016\/j.jsbmb.2013.05.008_bib0050","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"issue":"15","key":"10.1016\/j.jsbmb.2013.05.008_bib0055","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.jsbmb.2013.05.008_bib0060","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jsbmb.2013.05.008_bib0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"360","author":"Chlebowski","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"13","key":"10.1016\/j.jsbmb.2013.05.008_bib0070","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.05.008_bib0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.jsbmb.2013.05.008_bib0080","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jsbmb.2013.05.008_bib0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jnci\/djq141","article-title":"Comparing breast cancer risk assessment models","volume":"102","author":"Gail","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"issue":"9","key":"10.1016\/j.jsbmb.2013.05.008_bib0090","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djq099","article-title":"Overdiagnosis in cancer [Review] [43 refs]","volume":"102","author":"Welch","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"issue":"21","key":"10.1016\/j.jsbmb.2013.05.008_bib0095","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/archinte.168.21.2311","article-title":"The natural history of invasive breast cancers detected by screening mammography","volume":"168","author":"Zahl","year":"2008","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsbmb.2013.05.008_bib0100","doi-asserted-by":"crossref","first-page":"b2587","DOI":"10.1136\/bmj.b2587","article-title":"Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends [Review] [34 refs]","volume":"339","author":"Jorgensen","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jsbmb.2013.05.008_bib0105","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","article-title":"Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer","volume":"3","author":"Vogel","year":"2010","journal-title":"Cancer Prevention Research"},{"issue":"23","key":"10.1016\/j.jsbmb.2013.05.008_bib0110","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.jsbmb.2013.05.008_bib0115","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.jsbmb.2013.05.008_bib0120","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1158\/1055-9965.EPI-12-0043","article-title":"Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy","volume":"21","author":"Santen","year":"2012","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"1","key":"10.1016\/j.jsbmb.2013.05.008_bib0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/1096-9098(199601)61:1<68::AID-JSO2930610102>3.0.CO;2-E","article-title":"Rates of growth of human neoplasms: Part II [Review] [68 refs]","volume":"61","author":"Spratt","year":"1996","journal-title":"Journal of Surgical Oncology"},{"key":"10.1016\/j.jsbmb.2013.05.008_bib0130","first-page":"56","article-title":"The MISCAN-Fadia continuous tumor growth model for breast cancer","volume":"36","author":"Tan","year":"2006","journal-title":"Journal of the National Cancer Institute"},{"issue":"12","key":"10.1016\/j.jsbmb.2013.05.008_bib0135","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/cncr.11434","article-title":"A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena","volume":"97","author":"Kopans","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jsbmb.2013.05.008_bib0140","doi-asserted-by":"crossref","DOI":"10.1007\/s12672-013-0145-y","article-title":"Occult breast tumor reservoir: biologic properties and clinical significance","author":"Santen","year":"2013","journal-title":"Hormones and Cancer"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.05.008_bib0145","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10549-010-1153-z","article-title":"Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association","volume":"126","author":"Majed","year":"2011","journal-title":"Breast Cancer Research & Treatment"},{"issue":"1","key":"10.1016\/j.jsbmb.2013.05.008_bib0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1021649019025","article-title":"Apoptotic action of estrogen [Review] [63 refs]","volume":"8","author":"Song","year":"2003","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.05.008_bib0155","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2009.05.094","article-title":"Endometrial effects of a tissue selective estrogen complex containing bazedoxifene\/conjugated estrogens as a menopausal therapy","volume":"92","author":"Pickar","year":"2009","journal-title":"Fertility & Sterility"},{"issue":"7","key":"10.1016\/j.jsbmb.2013.05.008_bib0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/11316000-000000000-00000","article-title":"Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms [Review] [110 refs]","volume":"27","author":"Archer","year":"2010","journal-title":"Drugs & Aging"},{"issue":"6","key":"10.1016\/j.jsbmb.2013.05.008_bib0165","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/gme.0b013e3181a7fb1e","article-title":"The effects of bazedoxifene on mammographic breast density in postmenopausal women with osteoporosis","volume":"16","author":"Harvey","year":"2009","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.05.008_bib0170","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","volume":"92","author":"Lobo","year":"2009","journal-title":"Fertility & Sterility"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.05.008_bib0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/gme.0b013e3181b7c65f","article-title":"A randomized, placebo- and active-controlled trial of bazedoxifene\/conjugated estrogens for treatment of moderate to severe vulvar\/vaginal atrophy in postmenopausal women","volume":"17","author":"Kagan","year":"2010","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.05.008_bib0180","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00198-010-1440-x","article-title":"Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene\/conjugated estrogens (BZA\/CE) [Review]","volume":"22","author":"Lindsay","year":"2011","journal-title":"Osteoporosis International"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.05.008_bib0185","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/13697130903305627","article-title":"Effects of bazedoxifene\/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar\/vaginal atrophy","volume":"13","author":"Bachmann","year":"2010","journal-title":"Climacteric"},{"issue":"12","key":"10.1016\/j.jsbmb.2013.05.008_bib0190","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1517\/13543784.2010.532487","article-title":"Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women [Review]","volume":"19","author":"Pinkerton","year":"2010","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"6","key":"10.1016\/j.jsbmb.2013.05.008_bib0195","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/gme.0b013e3181a7df0d","article-title":"Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene\/conjugated estrogens: a randomized, controlled trial","volume":"16","author":"Pinkerton","year":"2009","journal-title":"Menopause"},{"issue":"9354","key":"10.1016\/j.jsbmb.2013.05.008_bib0200","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of the main outcomes in breast-cancer prevention trials [Review] [9 refs]","volume":"361","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2013.05.008_bib0205","first-page":"651","article-title":"Effects of the CE\/BZA tisue selective estrogen complex on breast cancer in nude mice","volume":"154","author":"Yan","year":"2013","journal-title":"Endorinology"},{"key":"10.1016\/j.jsbmb.2013.05.008_bib0210","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1210\/en.2012-1583","article-title":"Inhibitory effects of a bazedoxifene\/conjugated effects of the conjugated equine estrogen\/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice","volume":"153","author":"Yan","year":"2012","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.05.008_bib0215","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10549-010-1301-5","article-title":"Tetra-methoxystilbene modulates ductal growth of the developing murine mammary gland","volume":"126","author":"Kim","year":"2011","journal-title":"Breast Cancer Research & Treatment"},{"issue":"1","key":"10.1016\/j.jsbmb.2013.05.008_bib0220","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1210\/endo.141.1.7270","article-title":"Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo","volume":"141","author":"Shim","year":"2000","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.jsbmb.2013.05.008_bib0225","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1210\/en.2012-1583","article-title":"Effects of the conjugated equine estrogen\/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice","volume":"153","author":"Song","year":"2012","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.jsbmb.2013.05.008_bib0230","first-page":"890","article-title":"Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis","volume":"15","author":"Wood","year":"2008","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.jsbmb.2013.05.008_bib0235","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0093-7754(01)90133-2","article-title":"Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience","volume":"28","author":"Fisher","year":"2001","journal-title":"Seminars in Oncology"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.05.008_bib0240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0025-5564(01)00054-2","article-title":"A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening","volume":"171","author":"Plevritis","year":"2001","journal-title":"Mathematical Biosciences"},{"issue":"16","key":"10.1016\/j.jsbmb.2013.05.008_bib0245","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/jnci\/djq271","article-title":"A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40\u201349 years","volume":"102","author":"Bailey","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.jsbmb.2013.05.008_bib0250","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/1097-0142(196412)17:12<1501::AID-CNCR2820171202>3.0.CO;2-P","article-title":"Bilateral primary breast cancer; a prospective clinicopathological study","volume":"17","author":"Robbins","year":"1964","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jsbmb.2013.05.008_bib0255","first-page":"904","article-title":"Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up","volume":"106","author":"Rosen","year":"1989","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.jsbmb.2013.05.008_bib0260","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1470-2045(12)70075-X","article-title":"Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial","volume":"13","author":"Anderson","year":"2012","journal-title":"Lancet Oncology"},{"issue":"5","key":"10.1016\/j.jsbmb.2013.05.008_bib0265","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1210\/en.2008-1195","article-title":"Mechanisms of resistance to structurally diverse antiestrogens differ under premenopausal and postmenopausal conditions: evidence from in vitro breast cancer cell models","volume":"150","author":"Fan","year":"2009","journal-title":"Endocrinology"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076013000794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076013000794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:45:33Z","timestamp":1760744733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076013000794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":53,"alternative-id":["S0960076013000794"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.05.008","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718019043.793478432","asserted-by":"object"}]},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of menopausal hormonal therapy on occult breast tumors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}